CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Alembic Therapeutics LLC Announces Exclusive U.S. Distribution of NUVESSA® (metronidazole vaginal gel 1.3%)

PartnershipNUVESSAPositive
AI Analysis

Summary

Alembic Therapeutics LLC announced it will have exclusive U.S. distribution rights for NUVESSA (metronidazole vaginal gel 1.3%), a vaginal antibiotic product.

Importance:3/10
Sentiment:
0.50
distribution agreementpartnershipwomen's health

Read the original article

Published by GlobeNewswire Pharma on July 15, 2026 1:07 PM

Read Original